UNeMed Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UNeMed Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10536
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unemed Corp (Unemed), a subsidiary of University of Nebraska Medical Center, is a healthcare service provider. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies include therapeutics, diagnostics, drug delivery, research tools, medical devices, software, and educational materials. Unemed provides technologies in the field of cancer, cardiovascular, drug delivery, infectious diseases, medical devices, metabolic and neurologic. The company’s intellectual property protection and commercialization services for inventions developed with processing material transfer agreements and confidentiality disclosure agreements. It has a portfolio of technologies available for licensing. Unemed offers technology transfer and commercialization services. The company offers technology licensing process for industrial sectors. Unemed is headquartered in Omaha, Nebraska, the US.

UNeMed Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UNeMed Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UNeMed Corp, Medical Devices Deals, 2012 to YTD 2018 9
UNeMed Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UNeMed Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Calidum Enters into License Agreement with UNeMed 11
PlasmaTech Biopharma Enters into Licensing Agreement with UNeMed 12
ProTransit Nanotherapy Enters Into Licensing Agreement With UNeMed 13
UNeMed Corp – Key Competitors 14
UNeMed Corp – Key Employees 15
UNeMed Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
UNeMed Corp, Pharmaceuticals & Healthcare, Key Facts 2
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UNeMed Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UNeMed Corp, Deals By Therapy Area, 2012 to YTD 2018 8
UNeMed Corp, Medical Devices Deals, 2012 to YTD 2018 9
UNeMed Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Calidum Enters into License Agreement with UNeMed 11
PlasmaTech Biopharma Enters into Licensing Agreement with UNeMed 12
ProTransit Nanotherapy Enters Into Licensing Agreement With UNeMed 13
UNeMed Corp, Key Competitors 14
UNeMed Corp, Key Employees 15
UNeMed Corp, Other Locations 16

List of Figures
UNeMed Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UNeMed Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UNeMed Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UNeMed Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[UNeMed Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Business Development Bank Of Canada
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CSL Limited:企業のM&A・事業提携・投資動向
    CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Gale Pacific Ltd (GAP):企業の財務・戦略的SWOT分析
    Gale Pacific Ltd (GAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Northfork Electric Cooperative, Inc.:発電所・企業SWOT分析
    Northfork Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Dynacq Healthcare Inc (DYII):企業の財務・戦略的SWOT分析
    Summary Dynacq Healthcare Inc (DHI) is a healthcare consulting organization that provides surgical services. The organization develops and manages general acute hospitals that provide general surgeries. Its hospitals are designed to handle operations such as orthopaedics, neurosurgery and general su …
  • Nova Ljubljanska banka d.d.:企業の戦略・SWOT・財務分析
    Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report Summary Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066)-医療機器分野:企業M&A・提携分析
    Summary Shandong Weigao Group Medical Polymer Company Ltd (Weigao) researches, develops, manufactures and sells disposable medical consumables, orthopedic materials and blood purification products. Its products include infusion sets, needles, blood bags, heart eluting stents, blood sampling products …
  • Pinsent Masons LLP:企業の戦略的SWOT分析
    Pinsent Masons LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Solasia Pharma KK (4597)-製薬・医療分野:企業M&A・提携分析
    Summary Solasia Pharma KK (Solasia Pharma) formerly JapanBridge Inc is a healthcare service provider that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive care products. Its products include transdermal system whi …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Enero Group Limited (EGG):企業の財務・戦略的SWOT分析
    Enero Group Limited (EGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Advaxis Inc (ADXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm …
  • Profire Energy Inc (PFIE):企業の財務・戦略的SWOT分析
    Summary Profire Energy Inc (Profire Energy) is an oilfield technology company that undertakes design, development, and installation of combustion management technology and chemical injection solutions. The company offers products such as burner management systems and chemical management systems. Its …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kronos Incorporated:企業の戦略・SWOT・財務分析
    Kronos Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kronos Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆